Merck Defends Vioxx as 'One of Most-Studied' Drugs at Latest Trial

National News • March 8, 2006

An attorney for Merck & Co. insisted at the start of another Vioxx trial that the company adequately investigated the drug's safety and asserted it was heart disease and other ailments, not Vioxx, ...